Bolt Biotherapeutics, Inc. — Form 3
Filed October 27, 2026 · analyzed by the Insider Agent
3
— Neutral
significance 15/100
What the filing says
Chief Strategy Officer GUJRATHI SHEILA (BOLT) filed a statement of beneficial ownership. Initial/annual holdings — no market transaction.
Why this rating
Ownership statement, no transaction.
See more from October 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.